Company profile
Cocrystal Pharma, Inc.
NASDAQ:COCPBiotechnology: Pharmaceutical Preparations
Clinical trials (6)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02760758 | phase1 | completed | 2016-04-01 | 2017-03-01 | Cocrystal Pharma, Inc. | A Study of CDI-31244: A Novel NNI in HV and HCV Infected Subjects |
| NCT07198139 | phase1_2 | recruiting | 2026-03-01 | 2026-10-01 | Cocrystal Pharma, Inc. | A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus |
| NCT05202379 | phase1 | completed | 2022-02-11 | 2023-03-29 | Cocrystal Pharma, Inc. | CC-42344 Safety Study in Healthy Participants |
| NCT05977140 | phase1 | completed | 2023-09-27 | 2025-05-23 | Cocrystal Pharma, Inc. | CDI-988 Safety Study in Healthy Participants |
| NCT06160531 | phase2 | completed | 2023-11-25 | 2024-05-03 | Cocrystal Pharma, Inc. | Influenza Viral Challenge Study of CC-42344 in Healthy Participants |
FDA applications (0)
No records yet.